Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and efficacy of Lactobacillus supernatant spray for second-degree burn wounds
IRCT20210524051384N9Phase 2Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Jun 2023
- Modality
- Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of lactobacillus supernatant in burn injury, sponsored by Guilan University of Medical Sciences. Started Jun 2023; status: completed.
02
Drugs
lactobacillus supernatant
03
Conditions
burn injury
Beyond the preview
Go deeper on IRCT20210524051384N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210524051384N9.